These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10922306)

  • 1. Hematocrit levels and associated Medicare expenditures.
    Collins AJ; Li S; Ebben J; Ma JZ; Manning W
    Am J Kidney Dis; 2000 Aug; 36(2):282-93. PubMed ID: 10922306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and economic significance of iron replacement in anemia treated with recombinant human erythropoietin in patients on hemodialysis].
    Vanková S; Safárová R; Horácková M; Herink J; Rychlík I; Bahbouh R; Půtová I
    Cas Lek Cesk; 2001 Apr; 140(7):209-13. PubMed ID: 11374225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project.
    Kosiborod M; Curtis JP; Wang Y; Smith GL; Masoudi FA; Foody JM; Havranek EP; Krumholz HM
    Arch Intern Med; 2005 Oct; 165(19):2237-44. PubMed ID: 16246989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of dialysis and its relationship to dialysis adequacy, anemia management, and serum albumin level.
    Rocco MV; Bedinger MR; Milam R; Greer JW; McClellan WM; Frankenfield DL
    Am J Kidney Dis; 2001 Oct; 38(4):813-23. PubMed ID: 11576885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in anemia treatment with erythropoietin usage and patient outcomes.
    Collins AJ; Ma JZ; Xia A; Ebben J
    Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S133-41. PubMed ID: 9892380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
    Nissenson AR
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of urea reduction ratio and hematocrit data reported in different data systems: results from the Centers for Medicare & Medicaid Services and the Renal Network Inc.
    Frankenfield DL; Brier ME; Bedinger MR; Milam RA; Eggers PW; Cain JA; Aronoff GR; Frederick PR
    Am J Kidney Dis; 2003 Feb; 41(2):433-41. PubMed ID: 12552507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of intravenous levocarnitine on subsequent-month hospitalization among prevalent hemodialysis patients, 1998 to 2003.
    Weinhandl ED; Rao M; Gilbertson DT; Collins AJ; Pereira BJ
    Am J Kidney Dis; 2007 Nov; 50(5):803-12. PubMed ID: 17954293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.
    Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW
    Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between hematocrit level and mortality in hemodialysis patients. Case study of the anemic patient.
    Collins A; Ellefson J
    Nephrol Nurs J; 2000 Apr; 27(2):233-6. PubMed ID: 11111551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval.
    Powe NR; Griffiths RI; de Lissovoy G; Anderson GF; Watson AJ; Greer JW; Herbert RJ; Eggers PW; Milam RA; Whelton PK
    JAMA; 1992 Sep; 268(11):1434-40. PubMed ID: 1512912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs.
    Daviglus ML; Liu K; Greenland P; Dyer AR; Garside DB; Manheim L; Lowe LP; Rodin M; Lubitz J; Stamler J
    N Engl J Med; 1998 Oct; 339(16):1122-9. PubMed ID: 9770560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anemia and survival in Thai hemodialysis patients: evidence from national registry data.
    Krairittichai U; Supaporn T; Aimpun P; Wangsiripaisan A; Chaiprasert A; Sakulsaengprapha A; Chittinandana A; Thanachartwet W; Palasawatdhi V; Srangsomwong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S242-7. PubMed ID: 17044478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anemia treatment in the pre-ESRD period and associated mortality in elderly patients.
    Xue JL; St Peter WL; Ebben JP; Everson SE; Collins AJ
    Am J Kidney Dis; 2002 Dec; 40(6):1153-61. PubMed ID: 12460033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a change in epoetin alfa reimbursement policy on anemia outcomes in hemodialysis patients.
    Berns JS; Fishbane S; Elzein H; Lynn RI; Deoreo PB; Tharpe DL; Meisels IS
    Hemodial Int; 2005 Jul; 9(3):255-63. PubMed ID: 16191075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of donepezil use in routine clinical practice on health care costs in patients with Alzheimer's disease and related dementias enrolled in a large medicare managed care plan: a case-control study.
    Lu S; Hill J; Fillit H
    Am J Geriatr Pharmacother; 2005 Jun; 3(2):92-102. PubMed ID: 16129386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Late nephrology referral influences on morbidity and mortality of hemodialysis patients. A provincial study].
    Peña JM; Logroño JM; Pernaute R; Laviades C; Virto R; Vicente de Vera C
    Nefrologia; 2006; 26(1):84-97. PubMed ID: 16649429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.